Relmada Therapeutics Appoints Dr. Maurizio Fava as Chair of the Dextromethadone Scientific Advisory Board for its Depression Program

By WebmasterJune 28, 2017November 1st, 2024No Comments

Relmada Therapeutics Appoints Dr. Maurizio Fava as Chair of the Dextromethadone Scientific Advisory Board for its Depression Program

Previous PostVenatoRx Raises $42 Million Series B: Versant, Abingworth, Foresite Back Industry-Leading Antibiotics Developer
Next PostDr. Ottavio Vitolo Appointed Executive Clinical Advisor at Relmada Therapeutics